Motif Bio Share Discussion Threads

[scottdavid70] 21/12/2020 07:25

Fair to say I think this is ‘attempt’; at a RTO with ‘several’; companies who want to get their Covid therapeutics is beginning to feel like a huge con. After over 70 days since several term sheets were agreed and we are in a huge tsunami of Covid cases worldwide and vaccines causing adverse reactions they can’t close a deal suggests there wasn’t one to begin with. Happy to be proved wrong but can’t see a deal being done now in the timeframe they have left

[scottdavid70] 20/12/2020 15:29

18 December 2018

Clinical stage bio company Motif Bio could see its share price surge early next year, argued Peel Hunt, with the US FDA due to give possible approval to Motif's antibiotic iclaprim on 13 February. Trading at 26p, Peel Hunt is targeting 95p.

There they were again - Peel Hunt

Wrong then and more than likely wrong choice for the company now but they know the skeletons so an easy choice maybe?

[scottdavid70] 20/12/2020 15:20

Why did Motif Boo raise $10 million in May 2018 when they had said they were fully funded to FDA decision?

Why with this extra cash that they supposedly didn’t originally need did Motif then also pull EMA submission and HARP trials?

Second chapter will explain in the book

[scottdavid70] 20/12/2020 13:04

Pfizer vaccine paused in multiple US states as there are many allergic reactions. One Chicago hospital has stopped the program as 4 workers have suffered reactions

If there is genuinely a company wanting a Covid therapeutic to come to market there has been without a shadow of a doubt no better time to show it and do a deal with Motif.

Let’s see next week. Hopes are low obviously as we haven’t had a review of the Board last year to determine if the BOD members were of the best skill set shareholders needed for the restructured company

That’s why have you have Corporate Governance

[scottdavid70] 20/12/2020 12:00

US $ 25,000 reason for Jon “deferring his” Gold to run this into January plus a potential $325,000 bonus for a RTO which is happening off the back of failure. Sweet deal if you are the one driving the company isn’t?

[scottdavid70] 20/12/2020 04:59

No wonder they didn’t want a Board review into their behaviour in 2019. Makes total sense now. Corporate Governance would have had a field day

[scottdavid70] 20/12/2020 04:59

Even this years fund raise on the 5th May was to keep Jon’s “deferred̶1;
Gold in place despite him adding zero value to shareholders to date.

Imagine raising cash after destroying investors shareholding’s, in some cases maybe their pensions or large part of their savings just to pay yourself an unjustified salary?

[scottdavid70] 20/12/2020 04:41

Shareholders wouldn’t have needed two funds raises if they had actually dole as they said and operated under “strict cost controls”. It’s disgusting

[scottdavid70] 20/12/2020 04:39

I still can’t get over the fact they “Deferred̶1; Gold and “Greedy” Graham took home nearly US $1.1 million dollars between them during a year when the company was under “strict cost controls”

Imagine how much less dilution investors would have felt if they had actually deferred their salaries or operated on a more conscionable one?

[scottdavid70] 19/12/2020 21:12

Well if there is no announcement about getting a Covid therapeutic potentially to market given the chaos in the world right now then you can be forgiven this whole last 7 months was a total scam.

Beds globally at an absolute premium. If you don’t do a deal now it never existed in my humble opinion

[scottdavid70] 19/12/2020 15:49

You would like to think John Palmer of Tamarack would have run the document through spell check if it’s so important as it is to investors who were failed here by management. They can’t even spell Iclaprim correctly once which is massively disappointing

[scottdavid70] 19/12/2020 15:22

For example this from the Interims about the 30 companies they have diligently reviewed

“ More than 30 opportunities have been carefully reviewed by the Board and discussions have progressed to the term sheet stage with several companies. The search is continuing for an appropriate RTO candidate with the goal of completing a transaction before 28 January 2021”

Do they mean they ‘have’ which was current on the 12th October and still negotiating or ‘have’ but are no longer?

The curtains of opaqueness is a set of principles Motif Bio, Walbrook PR and Peel Hunt have lived behind since 2015

[scottdavid70] 19/12/2020 13:37

The more you dig the more you find

[scottdavid70] 19/12/2020 12:33

When you look at John Palmers Tamarack Associates on LinkedIn and the 2 page document outlining the reasons to buy Iclaprim you have to ask yourself why it doesn’t mention the tie up with Lamellar and the cystic fibrosis that Graham took a grant for as well as it’s evaluation of Listeria using Iclaprim.

Reading through it you can help but feel it’s a half hearted effort personally

[scottdavid70] 19/12/2020 11:14

Merely observed this STUNNING revelation that the Board decided to give themselves another Christmas present in 2019 along with the OUTRAGEOUS US$1.1 million that was paid to two directors whom were under “strict cost controls” by not reviewing their pitiful performance for shareholders.

You can tell this omission of a review is a erroneous development that should never of been allowed to happen by their tone in the Annual Report

[bi11y ray va1entine] 19/12/2020 11:10

I'm stunned that you think "stunned" means "merely observed". Ok that's a lie, I'm just mildly amused.

[scottdavid70] 19/12/2020 10:59

Even the auditors are STUNNED in the Annual Report as they talk about the LACK OF A BOARD REVIEW INDIVIDUALLY OR COLLECTIVELY when they say “it’s is intended that this will be addressed following completion of a RTO or other qualifying transaction which may result in changes to the Board”

Intended to address? What’s the point their whole ridiculous salary was based on getting Iclaprim approved but then told us they were implementing’strict cost controls” but took home 2
Of them almost US $1.1 MILLION

I could do that review in 2 minutes. You are completely out of your depth, have failed your shareholders and should pack your things now.

To not be reviewed is a scandal amongst the many here

[scottdavid70] 19/12/2020 10:36

But the bigger point is here without the review how do you know the Board members who have put the company in the abyss have the right skill set business wise to get you out of the abyss?

How many of the current Board members on December 31st 3019 for example had been involved with a AIM Cash Shell and had done a Reverse Takeover for instance?

I’ll wait...

[scottdavid70] 19/12/2020 10:34

How do you know without a comprehensive review of the Board members performance individually and collectively what went wrong, who said what and what could have been done differently?

[scottdavid70] 19/12/2020 10:33

How many people here have run companies where after a terrible, horrendous year you decide to not to do a review of the individuals who caused that particular disaster?

[scottdavid70] 19/12/2020 08:51

No wonder they decided as a group not or hold Board reviews individually or collectively after that sum of investors cash was shovelled into their respective accounts

[lithological heterogeneities] 19/12/2020 08:34

Have to say it's not looking good at all.

[scottdavid70] 19/12/2020 08:24

Answers on an email to Motif Bio and Walbrook PR

Who thinks Graham Lumsden and Jon Golds take home pay collectively in 2019 of almost US $1.1 MILLION DOLLARS constitutes’strict cost controls’ that they kept telling investors was in place?

[scottdavid70] 19/12/2020 05:34

Usually I would agree but have used a fair bit of my contacts in various areas of the media and have several ways of making some income from this story once the final chapter is written of the book.

Thanks for the advice. Am hoping all of you holding shares here get a good result ultimately

[smcl] 18/12/2020 20:32

SD70- just a word of advice. Be careful what you do. Group intervention is better!